Get our top picks of the posters at AACR 2025 and learn more about the method behind them and the techniques used.

ELRIG, a not-for-profit, volunteer-led organization dedicated to the global drug discovery community, has revealed the keynote speakers for its flagship event, Drug Discovery 2025. Taking place at the ...

CROs Advance Pharmaceutical Innovation with Thermo Fisher Scientific In today’s fast-paced pharmaceutical landscape, Contract ...

organised a poster-making activity on the pressing social issue of drug abuse. Students participated with great enthusiasm and used art... The Tribune, now published from Chandigarh, started ...

Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have ...

The conference attracts over 1,500 life science industry professionals from the world’s leading pharmaceutical companies, venture capital firms, and research institutions. LABEST is intended to ...

today announced preclinical data from four pipeline programs during poster sessions at the American Association for Cancer Research (AACR) 2025 Annual Meeting taking place in Chicago.

“We need to take care of it.” Such stories of personal connection to research weren’t uncommon at the UB RENEW Institute’s spring poster session and end-of-year celebration last week in Davis Hall.

The efficacy of anticancer gene therapy varies by the delivery efficiency of the mRNA cargo as well as their injection method. Here this group reports using LNP-delivered mRNA encoding 3 C ...

to survivorship and advocacy—and highlights the work of the best minds in research and medicine from institutions all over the world. About BXQ-350 Bexion's lead drug candidate is BXQ-350 ...

Drug development describes the process of developing a new drug that effectively targets a specific weakness in a cell. This process involves specific pre-clinical development and testing ...